Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

NCT01250366 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV (Genotype 1)

Interventions

DRUG: INX-08189
DRUG: INX-08189
DRUG: INX-08189
DRUG: INX-08189
DRUG: INX-08189
DRUG: INX-08189
DRUG: INX-08189
DRUG: Placebo matching with INX-08189
DRUG: Ribavirin

Sponsor

Bristol-Myers Squibb